Q2 2024 EPS Estimates for Encompass Health Co. (NYSE:EHC) Reduced by William Blair

Encompass Health Co. (NYSE:EHC) – William Blair lowered their Q2 2024 earnings per share (EPS) estimates for Encompass Health in a research report issued on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will post earnings per share of $0.96 for the quarter, down from their prior forecast of $0.97. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $3.96 per share. William Blair also issued estimates for Encompass Health’s Q3 2024 earnings at $0.94 EPS, Q4 2024 earnings at $0.99 EPS, FY2024 earnings at $4.01 EPS, Q3 2025 earnings at $1.07 EPS, Q4 2025 earnings at $1.13 EPS and FY2025 earnings at $4.58 EPS.

Several other research firms have also recently weighed in on EHC. Royal Bank of Canada reissued an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Raymond James reaffirmed a “strong-buy” rating and issued a $95.00 price objective (up from $85.00) on shares of Encompass Health in a report on Friday. Barclays lifted their price objective on Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday. Mizuho lifted their price objective on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Thursday. Finally, Truist Financial lifted their price objective on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a report on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Encompass Health has a consensus rating of “Buy” and an average price target of $86.56.

Encompass Health Stock Performance

NYSE:EHC opened at $82.46 on Friday. The stock has a market cap of $8.26 billion, a P/E ratio of 22.29, a PEG ratio of 1.53 and a beta of 0.94. The stock has a 50 day simple moving average of $78.25 and a 200 day simple moving average of $70.87. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.19. Encompass Health has a 1-year low of $57.55 and a 1-year high of $85.84.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. The business had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.48% and a net margin of 7.60%. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same period last year, the firm posted $0.88 EPS.

Hedge Funds Weigh In On Encompass Health

Hedge funds and other institutional investors have recently modified their holdings of the business. International Assets Investment Management LLC bought a new position in shares of Encompass Health in the 4th quarter valued at $20,210,000. Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Encompass Health by 2.3% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 1,318,784 shares of the company’s stock valued at $87,989,000 after purchasing an additional 29,926 shares during the last quarter. Phocas Financial Corp. grew its position in Encompass Health by 112.4% during the 4th quarter. Phocas Financial Corp. now owns 99,875 shares of the company’s stock worth $6,664,000 after acquiring an additional 52,847 shares during the last quarter. Nordea Investment Management AB grew its position in Encompass Health by 21.0% during the 4th quarter. Nordea Investment Management AB now owns 101,705 shares of the company’s stock worth $6,787,000 after acquiring an additional 17,684 shares during the last quarter. Finally, Oak Thistle LLC grew its position in Encompass Health by 19.1% during the 4th quarter. Oak Thistle LLC now owns 14,436 shares of the company’s stock worth $963,000 after acquiring an additional 2,319 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.15 dividend. The ex-dividend date was Thursday, March 28th. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. Encompass Health’s payout ratio is 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.